Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current Assets:    
Cash $ 28,746,456 $ 24,782,128
Accounts receivable, net 372,971 1,373,754
Prepaid expenses and other current assets 625,643 107,651
Total Current Assets 29,745,070 26,263,533
Intangible assets, net 2,440,316 1,071,850
Property and equipment, net 34,035 17,166
Deferred offering costs 37,510 10,000
Total Assets 32,256,931 27,362,549
Current Liabilities:    
Accounts payable - suppliers 451,709 336,028
Accounts payable - trade 817,389 1,106,604
Accrued expenses and other current liabilities 921,990 1,032,282
Notes payable 260,322 218,461
Total Current Liabilities 2,451,410 2,693,375
Notes payable, non-current portion 77,422 187,629
Total Liabilities 2,528,832 2,881,004
Commitments and contingencies (Note 6)
Stockholders' Equity :    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of September 30, 2021 and December 31, 2020 0 0
Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,252,886 and 11,756,109 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 143 118
Additional paid-in capital 51,827,263 40,770,504
Accumulated deficit (22,099,307) (16,289,077)
Total Stockholders' Equity 29,728,099 24,481,545
Total Liabilities and Stockholders' Equity $ 32,256,931 $ 27,362,549